MedCity News December 19, 2024
Frank Vinluan

Applications of SandboxAQ’s large quantitative models (LQMs) technology include running simulations that identify new biomarkers and optimize clinical development of drug candidates. The company spun out of Alphabet in 2022.

Artificial intelligence technology company SandboxAQ has raised $300 million to accelerate development of technologies with applications in a range of industries, including the life sciences.

Palo Alto, California-based SandboxAQ, a spinout of Alphabet, specified that the new funding announced Wednesday will support development of large quantitative models (LQMs), which are models that process and analyze large datasets. That’s in contrast to large language models (LLMs) that analyze text.

SandboxAZ says its LQMs are used by companies in the life sciences, energy, financial services, government, telecommunications, and more. In drug research,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: AI (Artificial Intelligence), Biotechnology, Investments, Pharma, Pharma / Biotech, Technology, Trends
Related Articles:
This Is Not Broadcom’s ‘Nvidia Moment’ Yet
ChatGPT adds more PC and Mac app integrations, getting closer to piloting your computer
AI Fuels Tech Surge as Micron, Databricks and Basis Ride Wave of Growth
AI Translator Could Be ROI Boon
‘Orgs need to be ready’: AI risks and rewards for cybersecurity in 2025

Share This Article